Further evidence that the combined use of vaccines and COX2 inhibitors may delay or eliminate LS polyp formation to carcinoma was provided in a study employing a therapeutic CEA-targeting vaccine, designed to induce CEA-specific T cells and celecoxib. This evidence concerns the gene CEACAM5 and Leigh syndrome.